Pharm Plan Minutes 2014.10.29
08:00 - 08:15 Welcome
- Participants
- Jürgen Brandstätter
- Leonidas Tzimis
- Jose Costa Teixeira
- Michael Tan
- Jacqueline Surugue
- Marc Robberecht
- Stephane Spahni
- Simon Lettelier
- Review and Approve Agenda
- Approved with changes in order
08:15 - 08:30 Schedule
- Current version:
- Open issues:
- Status of IHE Joint meeting with ITI, PCC and QRPH: 24-25 February 2015, ASIP Santé Offices, Paris, France (Jürgen)
- Jürgen has contacted Nancy and Celina, but hasn't received an answer yet.
- Action item: Do a follow-up (Jürgen)
- IHE Joint meeting with SIG HL7 Pharmacy : 15 May 2015, Paris, France (Jacqueline)
- Expected person count: 17
- Jacqueline has contacted Francois Macary, he said that he will check, but hasn't received an answer yet
- Action item: Do a follow-up (Jacqueline)
- Alternatives: Marc can ask at the AGFA office in Ivry / Paris
- Action item: Ask AGFA about the size of available meeting rooms
- Regular IHE F2F meeting : 18-19 June 2015, Chania (Crete), Greece
- Leonidas has 3 found opportunities for meeting place
- 1) Inside Leonidas' hospital of Chania
- 2) Building of the Private Pharmacists association of Chanis
- 3) Meeting room in the City hall. Major of the city has been contacted (best option)
- Leonidas will send out information for travel and accommodation
- IMPORTANT: Book room and flight early, because it's high holiday season at this time!
- City is small, hotels are all in the old city in the center of the town.
- Chania has an airport. Three flights to Athens per day. Ryan air operates.
- Bus from Heraklion to Chania takes about 2 hours.
08:30 - 09:00 Hospital-Community Use Cases Whitepaper
- Current version
- Discussion
- Can it be published? Open issues?
- Still needs some review/addition
- Decision: The Whitepaper will NOT be published itself, but will be inserted into the Common Pharmacy Whitepaper
- Project Management and Todos
- 1. Use-case in document "Collaboration between connected Hospital Pharmacies" will be merged into the Cross-Domain WP
- 2. Cross-domain WP + chapter 10 of Common Pharmacy WP will be reviewed
- Action item: Stephane & colleagues
- 3. Cross-domain WP will be merged into chapter 10 of Common Pharmacy WP. Cross-domain WP will be abandoned.
- 4. Overwork Information Model of Common Pharmacy WP
- 5. Publish new version of Common Pharmacy WP
- A "Use-case overview" document has been created and will be maintained from now on
- []
- Action item: Fill the document with all use-cases already defined (Jose)
- CMPD, HMW, Hospital&Community WP, Supply chain WP, General Pharmacy WP, etc.
09:15 - 10:45 Medication Treatment
- Proposal
- Vision of the work ahead (Jürgen, Stephane)
- Discussion
- Formal approval of the new work-item proposal
- Defining next steps
10:45 - 11:00 Break
11:00 - 12:30 Pharmacy Administration
- Current work:
- Wrapping up work done so far, open issues and how to continue (Jürgen)
- Discussion
- Defining next steps
12:30 - 13:30 Lunch
- PADV issue: Deep analysis of code "CHANGE" revealed that it actually means "CHANGE + OK" (= implies the OK too). Related to that, the state "OK" actually means "(Unchanged) OK"
- Question: Do we need a simple "CHANGE" which does not also imply the OK? Not needed for A, SA and CH -> at the moment it is an academic discussion
- DIS issue: The Dispenser also needs Profession and Specialty
- Proposal: Exchange <performer> by <author> for the Dispenser. Change <author> by a second <author> for a possible prescriber of the underlying prescription
- PADV issue: Requirement of CH: Providing comments to PRE or DIS items (e.g. The patient has problems swallowing the pill because it's too big).
- Possible solution: Extend PADV by a new code "COMMENT", which has no effect on the workflow, but just provides commenting information, e.g. as concern
- PRE issue: Precondition is often used to describe dosage related information (e.g. "Take on demand")
- Question: Shall it be moved under "Dosage instructions"?
- PADV, PML issue: The issue appears only, when a PRE entry is referenced in a PADV or embedded in a PML + this entry contains an internal reference in the "Reason" element (e.g. to a diagnosis expressed in an Active Problems section)
- Current solution in PADV: The section referenced is not included and instructions are given how to break the internal reference
- Proposed solution: CP on PADV and PML to allow 0..* additional sections to be added in order not to break the internal references. Those section do NOT belong to the PADV/PML document itself, but are just inserted to fulfill the internal reference
- PML issue: CH brought up that the PML might be used for "feeding" a medication plan
- Discussion: Currently PML is intended as a "read-only", on-demand document. Shall that be changed? Should we add a note somewhere to clarify?
14:00 - 15:15 ISO liaison
- Report on ISO meeting in Berlin (Jürgen)
- Commenting on ISO/DIS 17523 "Requirements for electronic prescriptions"
- ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions
- Comments received by Leonidas, Jose, Jürgen
- Defining next steps
- ISO DTS 19293 "Requirements for the record of Dispense Medicinal Products"
- Discussion
- Defining next steps
- ISO/DTS 17251, "Business requirements for the exchange of structured dose instructions for medicinal products"
- Discussion
- Defining next steps